|Bid||172.37 x 100|
|Ask||172.43 x 200|
|Day's Range||172.12 - 173.41|
|52 Week Range||161.09 - 209.22|
|PE Ratio (TTM)||176.79|
|Dividend & Yield||0.91 (0.53%)|
|1y Target Est||N/A|
All major pharma stocks were up this week with companies like Novartis (NVS) presenting positive data and others gaining FDA approval.
Shire plc (SHPG) announced that the European Medicines Agency (EMA) validated the Marketing Authorization Application (MAA) for Veyvondi to prevent and treat bleeding episodes and peri-operative bleeding in adults diagnosed with von Willebrand Disease.
Shire, Bellicum Pharmaceuticals and Organovo Holdings were among the biotech stock movers in premarket trading on June 22.